Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of PTC299 in Patients With HIV-Related Kaposi's Sarcoma

NCT00686842 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT00686842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00686842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of PTC299 in Patients With HIV-Related Kaposi's Sarcoma
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 1/2
Overall status
Terminated
Start date
September 30, 2008
Completion date
December 31, 2010
Enrollment
17 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

kaposi's sarcoma